Vidal-Puig A - Search Results

1

Publisher Correction: GDF15 mediates the effects of metformin on body weight and energy balance.

Coll AP, Chen M, Taskar P, Rimmington D, Patel S, Tadross JA, Cimino I, Yang M, Welsh P, Virtue S, Goldspink DA, Miedzybrodzka EL, Konopka AR, Esponda RR, Huang JT, Tung YCL, Rodriguez-Cuenca S, Tomaz RA, Harding HP, Melvin A, Yeo GSH, Preiss D, Vidal-Puig A, Vallier L, Nair KS, Wareham NJ, Ron D, Gribble FM, Reimann F, Sattar N, Savage DB, Allan BB, O'Rahilly S. Coll AP, et al. Nature. 2020 Feb;578(7796):E24. doi: 10.1038/s41586-020-2031-4. Nature. 2020. PMID: 32051582

2

Obesity and diabetes: an avalanche of new information.

Vidal-Puig A, O'Rahilly S. Vidal-Puig A, et al. Mol Med Today. 2000 Jun;6(6):221-3. doi: 10.1016/s1357-4310(00)01714-7. Mol Med Today. 2000. PMID: 10939842 No abstract available.

3

Metabolism. Controlling the glucose factory.

Vidal-Puig A, O'Rahilly S. Vidal-Puig A, et al. Nature. 2001 Sep 13;413(6852):125-6. doi: 10.1038/35093198. Nature. 2001. PMID: 11557965 No abstract available.

4

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.

Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S. Savage DB, et al. Diabetes. 2001 Oct;50(10):2199-202. doi: 10.2337/diabetes.50.10.2199. Diabetes. 2001. PMID: 11574398

5

Resistin: a new link between obesity and insulin resistance?

Vidal-Puig A, O'Rahilly S. Vidal-Puig A, et al. Clin Endocrinol (Oxf). 2001 Oct;55(4):437-8. doi: 10.1046/j.1365-2265.2001.01377.x. Clin Endocrinol (Oxf). 2001. PMID: 11678824 Review. No abstract available.

6

Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists.

Sewter CP, Blows F, Vidal-Puig A, O'Rahilly S. Sewter CP, et al. Diabetes. 2002 Mar;51(3):718-23. doi: 10.2337/diabetes.51.3.718. Diabetes. 2002. PMID: 11872672

7

Digenic inheritance of severe insulin resistance in a human pedigree.

Savage DB, Agostini M, Barroso I, Gurnell M, Luan J, Meirhaeghe A, Harding AH, Ihrke G, Rajanayagam O, Soos MA, George S, Berger D, Thomas EL, Bell JD, Meeran K, Ross RJ, Vidal-Puig A, Wareham NJ, O'Rahilly S, Chatterjee VK, Schafer AJ. Savage DB, et al. Nat Genet. 2002 Aug;31(4):379-84. doi: 10.1038/ng926. Epub 2002 Jul 15. Nat Genet. 2002. PMID: 12118251

8

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma.

Savage DB, Tan GD, Acerini CL, Jebb SA, Agostini M, Gurnell M, Williams RL, Umpleby AM, Thomas EL, Bell JD, Dixon AK, Dunne F, Boiani R, Cinti S, Vidal-Puig A, Karpe F, Chatterjee VK, O'Rahilly S. Savage DB, et al. Diabetes. 2003 Apr;52(4):910-7. doi: 10.2337/diabetes.52.4.910. Diabetes. 2003. PMID: 12663460

9

Genetic variants in human sterol regulatory element binding protein-1c in syndromes of severe insulin resistance and type 2 diabetes.

Laudes M, Barroso I, Luan J, Soos MA, Yeo G, Meirhaeghe A, Logie L, Vidal-Puig A, Schafer AJ, Wareham NJ, O'Rahilly S. Laudes M, et al. Diabetes. 2004 Mar;53(3):842-6. doi: 10.2337/diabetes.53.3.842. Diabetes. 2004. PMID: 14988272

10

Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis.

Lelliott CJ, López M, Curtis RK, Parker N, Laudes M, Yeo G, Jimenez-Liñan M, Grosse J, Saha AK, Wiggins D, Hauton D, Brand MD, O'Rahilly S, Griffin JL, Gibbons GF, Vidal-Puig A. Lelliott CJ, et al. FASEB J. 2005 Jul;19(9):1108-19. doi: 10.1096/fj.04-3196com. FASEB J. 2005. PMID: 15985534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

340 results

Search Page